Lower CSF taurine levels in male pathological gamblers than in healthy controls

Human Psychopharmacology

Volumn 11, Issue 5, 1996, Pages 401-403

  Nordin, Conny ^a,b   Eklundh, Thomas ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

amino acids; CSF; pathological gambling; taurine

Indexed keywords

TAURINE;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MALE; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL;

EID: 0029961842     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(199609)11:5<401::AID-HUP781>3.0.CO;2-1     Document Type: Article

References (13)

1. American Psychiatric Association (1987). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, revised. American Psychiatric Association, Washington, DC.
2. Bergh, C. and Kühlhorn, E. (1994a). The development of pathological gambling in Sweden. Journal of Gambling Studies, 10, 261-274.
3. Bergh, C. and Kühlhorn, E. (1994b). Social, psychological and physical consequences of pathological gambling in Sweden. Journal of Gambling Studies, 10, 275-285.
4. Bertilsson, L. and Åsberg, M. (1984). Amine metabolites in the cerebrospinal fluid as a measure of central neurotransmitter function : methodological aspects. In: Frontiers in Biochemical and Pharmacological Research in Depression, Usdin, E., Åsberg, M., Bertilsson, L. and Sjöqvist, F. (Eds), Raven Press, New York, pp. 27-34.
5. Durelli, L. and Mutani, R. (1983). The current status of taurine in epilepsy. Clinical Neuropharmacology, 6, 37-48.
6. van Gelder, N. M. (1972). Antagonism by taurine of cobalt induced epilepsy in cat and mouse. Brain Research, 47, 157-165.
7. Keränen, T., Partanen, V. S. K., Koivisto, K., Tokola, O., Neuvonen, P. J. and Riekkinen, P. J. (1987) Effects of Taltrimide, an experimental taurine derivative, on photoconvulsive response in epileptic patients. Epilepsia. 28, 133-137.
8. Kleinbaum, D. G., Kupper, L. L. and Muller, K. E. (1988). Applied Regression Analyses and Other Multivariable Methods. WS-KENT Publishing Company, Boston.
9. Koivisto, K., Sivenius, J., Keränen, T., Partanen, J., Riekkinen, P. and Gothoni, G. (1986). Clinical trial with an experimental taurine derivative, Taltrimide, in epileptic patients. Epilepsia, 27, 87-90.
10. Nordin, C., Swedin, A. and Zachau, A. (1993). Tapping-time influences concentrations of 5-HIAA in the CSF. Journal of Psychiatric Research, 27, 409-414.
11. Okamoto, K., Kimura, H. and Sakai, Y. (1983). Evidence for taurine as an inhibitory neurotransmitter in cerebellar stellate interneurons: selective antagonism by TAG (6-aminomethyl-3-methyl-4H,i,2,4-benzothiadiazine-1,1 -dioxide). Brain Research, 265, 163-168.
12. Qureshi, G. A. and Baig, S. M. (1993). Role of neurotransmitter amino acids in multiple sclerosis in exacerbation, remission and chronic progressive course. Biogenic Amines, 10, 39-48.
13. Roy, A., Adinoff, B., Roerich, L., Lamparski, D., Custer, R., Lorenz, V., Barbaccia, M., Guidotti, A., Costa, E. and Linnoila, M. (1988). Pathological gambling. A psychobiological study. Archives of General Psychiatry, 45, 369-373.